Westenfelder, Kay M;Lentes, Beatrice;Rackerseder, Julia;Navab, Nassir;Gschwend, Jürgen E;Eiber, Matthias;Maurer, Tobias.Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion Biopsy..Clin Genitourin Cancer.2018.16.4.245-247

Pfetsch, L.;Schiller, K.;Devecka, M.;Maurer, T.;Eiber, M.;Combs, S.;Habl, G..Follow-up of prostate cancer patients receiving 68Ga-PSMA-PET guided dose escalation radiotherapy.Radiother Oncol.2018.127.S859-S859

Schiller, K.;Devecka, M.;Maurer, T.;Eiber, M.;Combs, S. E.;Habl, G..Patterns of failure in a primary staging setting for prostate cancer evaluated with PSMA-PET imaging.Radiother Oncol.2018.127.S433-S434

Seitz, Anna-Katharina;Thoene, Silvia;Bietenbeck, Andreas;Nawroth, Roman;Tauber, Robert;Thalgott, Mark;Schmid, Sebastian;Retz, Margitta;Gschwend, Juergen;Ruland, Juergen;Winter, Christof;Heck, Matthias.PREDICTION OF TREATMENT RESISTANCE UNDER ABIRATERONE AND ENZALUTMIDE VIA DETECTION OF AR-V7 IN PERIPHERAL WHOLE BLOOD OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS.J Urol.2018.199.4.E305-E305

Horn, Thomas;Rauscher, Isabel;Eiber, Matthias;Wester, Hans-Juergen;Schottelius, Margret;Heck, Matthias Michael;Gschwend, Juergen E.;Maurer, Tobias.Oncological and postoperative outcome of salvage PSMA-radioguided surgery in recurrent prostate cancer..J Clin Oncol.2018.36.6

Rexer, H;Ohlmann, C-H;Retz, M.Erstlinientherapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom: Eine randomisierte, kontrollierte Phase-III-Studie zum Vergleich von Pembrolizumab mit und ohne platinbasierter Kombinations-Chemotherapie und der alleinigen Chemotherapie bei Patienten mit fortgeschrittenem oder metastasiertem Urothelkarzinom (Keynote-361) AB 54/16 der AUO..Aktuelle Urol.2018.49.1.21-22

Scheich, S.;Ahrens, M.;Goekbuget, N.;Boleti, E.;Burkholder, I;Escudier, B. J.;Goebell, P. J.;Gruenwald, V;Gschwend, J.;Retz, M.;Hartmann, A.;Maroto Rey, J. P.;Miller, K.;Grimm, M. -O;Siemer, S.;Panic, A.;Bergmann, L..SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma.Oncology Research and Treatment.2018.41.205-205

Retz, M;Karl, A.[Bladder cancer : Current diagnosis and treatment modalities]..Urologe A.2018.57.6.655-656

Thalgott, Mark;Kron, Martina;Brath, Johannes M;Ankerst, Donna P;Thompson, Ian M;Gschwend, Juergen E;Herkommer, Kathleen.Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy..World J Urol.2018.36.2.177-185

Heers, Hendrik;Netsch, Christopher;Wilhelm, Konrad;Secker, Armin;Kurtz, Florian;Spachmann, Philipp;Viniol, Simon;Hofmann, Rainer;Hegele, Axel.Diagnosis, Treatment, and Outcome of Arterioureteral Fistula: The Urologist's Perspective..J Endourol.2018.32.3.245-251